Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

149.80
Data as of Apr 17
 +0.75 / +0.50%
Today’s Change
87.01
Today|||52-Week Range
185.43
+12.73%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Bell Leonard
Chief Executive Officer
Sale12/18/201373,843$125.30$9.3M+16.44%
Madri Joseph A
Director
Sale3/11/201450,000$178.35$8.9M-14.86%
Hallal David L
EVP & Chief Commercial Officer
Sale7/12/201350,000$120.00$6.0M+31.10%
Sinha Vikas
Chief Financial Officer & Executive Vice President
Sale7/12/201350,000$120.00$6.0M+31.10%
Bell Leonard
Chief Executive Officer
Sale8/15/201356,278$106.36$6.0M+41.12%
Bell Leonard
Chief Executive Officer
Sale7/30/201350,967$110.53$5.6M+27.95%
Sinha Vikas
Chief Financial Officer & Executive Vice President
Sale10/28/201342,138$122.80$5.2M+20.61%
Bell Leonard
Chief Executive Officer
Sale1/21/201435,139$139.79$4.9M+5.06%
Squinto Stephen P
Sale10/28/201339,537$124.06$4.9M+20.61%
Mathis Larry L
Director
Sale2/03/201430,222$158.41$4.8M-3.15%
Page of 24

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.